The top amount of exits for fund were in 2019. The high activity for fund was in 2017. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Among the most popular portfolio startups of the fund, we may highlight Myonexus Therapeutics. Among the most popular fund investment industries, there are Therapeutics, Biotechnology.
The typical case for the fund is to invest in rounds with 4 participants. The meaningful sponsors for the fund in investment in the same round are Rev1 Ventures, GFB ONLUS, CincyTech. In the next rounds fund is usually obtained by Sarepta Therapeutics.
Related Funds
| Fund Name | Location |
| Aerofolks Group | Beijing, Beijing, China |
| Armor Angels | Bretagne, France, Saint-brieuc |
| BRED Banque | France, Ile-de-France, Paris |
| Concord New Energy Group | - |
| Coocaa | China, Guangdong, Shenzhen |
| Dia Vikas Capital | Gurgaon, Haryana, India |
| Efun | China, Guangdong, Guangzhou |
| Fairview Capital Partners | Connecticut, United States, West Hartford |
| HOWstore | China, Shanghai |
| Independence Equity | Illinois, Northbrook, United States |
| Insigma Technology | China, Hangzhou, Zhejiang |
| Jinfu Ziben | Beijing, Beijing, China |
| LDV Capital | New York, New York, United States |
| Leshi Qiche | - |
| Live Nation Labs | Beverly Hills, California, United States |
| MathCapital | New York, New York, United States |
| Moneta Ventures | California, Folsom, United States |
| Tanant Capital | - |
| Visionary Private Equity Group | Missouri, Saint Charles, United States |
| Yangli Konggu | China, Liaoning, Shenyang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Myonexus Therapeutics | $2M | 13 Dec 2017 | Columbus, Ohio, United States | ||
Myonexus Therapeutics | $2M | 29 Sep 2017 | Columbus, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Myonexus Therapeutics | $2M | 13 Dec 2017 | Columbus, Ohio, United States | ||
Myonexus Therapeutics | $2M | 29 Sep 2017 | Columbus, Ohio, United States |
